Regional outcomes after admission for high-risk non-ST-segment elevation acute coronary syndromes.

[1]  G. Lamas,et al.  ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction--executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to revise the 1999 guidelines for the management of patients wi , 2004, Journal of the American College of Cardiology.

[2]  S. Jencks,et al.  Change in the quality of care delivered to Medicare beneficiaries, 1998-1999 to 2000-2001. , 2003, JAMA.

[3]  Carl J Pepine,et al.  ACC/AHA guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction--2002: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients , 2002, Circulation.

[4]  H. White.  Thrombolytic therapy in the elderly , 2000, The Lancet.

[5]  W. Rogers,et al.  Temporal trends in the treatment of over 1.5 million patients with myocardial infarction in the US from 1990 through 1999: the National Registry of Myocardial Infarction 1, 2 and 3. , 2000, Journal of the American College of Cardiology.

[6]  B. McNeil,et al.  Appropriateness of coronary angiography after myocardial infarction among Medicare beneficiaries. Managed care versus fee for service. , 2000, The New England journal of medicine.

[7]  B. B. Fleming,et al.  Quality of medical care delivered to Medicare beneficiaries: A profile at state and national levels. , 2000, JAMA.

[8]  J. W. Schaeffer,et al.  ACC/AHA guidelines for the management of patients with unstable angina and non‐ST segment elevation myocardial infarction: Executive summary and recommendations , 2000, Circulation.

[9]  H. Krumholz,et al.  Thrombolytic therapy in older patients. , 2000, Journal of the American College of Cardiology.

[10]  N. Powe,et al.  Lack of benefit for intravenous thrombolysis in patients with myocardial infarction who are older than 75 years. , 2000, Circulation.

[11]  S. Jencks.  Clinical performance measurement--a hard sell. , 2000, JAMA.

[12]  J. Wennberg,et al.  Geographic variation in the treatment of acute myocardial infarction: the Cooperative Cardiovascular Project. , 1999, JAMA.

[13]  H. Krumholz,et al.  National use and effectiveness of beta-blockers for the treatment of elderly patients after acute myocardial infarction: National Cooperative Cardiovascular Project. , 1998, JAMA.

[14]  H. Krumholz,et al.  Improving the quality of care for Medicare patients with acute myocardial infarction: results from the Cooperative Cardiovascular Project. , 1998, JAMA.

[15]  W. O’Neill,et al.  Regional variation across the United States in the management of acute myocardial infarction. , 1995, The New England journal of medicine.

[16]  B. McNeil,et al.  Variation in the use of cardiac procedures after acute myocardial infarction. , 1995, The New England journal of medicine.

[17]  L Pilote,et al.  Regional variation across the United States in the management of acute myocardial infarction. GUSTO-1 Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries. , 1995, The New England journal of medicine.

[18]  K Y Liang,et al.  Longitudinal data analysis for discrete and continuous outcomes. , 1986, Biometrics.